SEPSET BIOSCIENCES

sepset-biosciences-logo

Sepset Biosciences Inc., a CDRD portfolio company, in collaboration with Dr. Robert Hancock and Dr. Olga Pena, at the University of British Columbia, is developing a first in class diagnostic assay for the early and rapid diagnosis of sepsis. This unique diagnostic is based on the detection of a unique signature of sepsis based on the immune response rather than the presences of a pathogen.

#Financial #Website #More

SEPSET BIOSCIENCES

Social Links:

Founded:
2016-01-01

Address:
Vancouver, British Columbia, Canada

Country:
Canada

Website Url:
http://www.sepset.ca

Status:
Active

Total Funding:
0

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Content Delivery Network Euro GoDaddy DNS Typekit Squarespace Squarespace Hosted


Investors List

canadian-institutes-of-health-research_image

Canadian Institutes of Health Research

Canadian Institutes of Health Research investment in Grant - Sepset Biosciences

accel-rx-health-sciences-accelerator_image

Accel-Rx Health Sciences Accelerator

Accel-Rx Health Sciences Accelerator investment in Pre Seed Round - Sepset Biosciences

Official Site Inspections

http://www.sepset.ca

  • Host name: 198.49.23.145
  • IP address: 198.49.23.145
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "Sepset Biosciences"

About Us — Sepset Biosciences Inc.

Overview. Sepset Biosciences is a medical diagnostic company in advanced development of a blood-based test (Sepset-ER) for hospitals to identify those patients in the emergency room (ER) and the intensive care unit (ICU) at a higher risk of developing sepsis and associated organ failure. Sepset’s test will provide much earlier (~1-2 hours) and more actionable information to …See details»

Our Team — Sepset Biosciences Inc.

Chief Financial Officer. Ms. Tucker is the president of J.M. Tucker Professional Corp. The company was established in 1995 in Vancouver, BC, providing audit and related financial services to emerging companies in the resource, bio …See details»

Sepset Biosciences - Crunchbase Company Profile & Funding

Sepset Biosciences Inc., a CDRD portfolio company. GlobeNewswire News Room — Sepsis Diagnostic Markets Global Market Forecasts 2024-2028: Instrumentation, Automation and Diagnostic Trends, Competitive Landscape, Recent Developments, Industry OverviewSee details»

Asep Medical Holdings Inc. Signs Joint Venture Agreement

Nov 22, 2023 Sepset Biosciences Inc. (www.sepset.ca) is in the final stages of preparation for clinical studies and commercialization of an in vitro diagnostic test that involves a patient gene expression ...See details»

Asep Medical Holdings Inc. Achieves Significant …

Dec 23, 2022 The Sepset ER test is a blood-based gene expression assay that is straightforward to implement, and results are obtained in about an hour in the emergency room or intensive care unit. This ...See details»

Sepset Biosciences Inc Company Profile - Dun & Bradstreet

Sepset Biosciences Inc Company Profile | Vancouver, BC, Canada | Competitors, Financials & Contacts - Dun & BradstreetSee details»

Asep Medical Holdings Inc. Achieves Significant Milestones …

Sepset Biosciences Inc. (sepset.ca) is developing a diagnostic technology that involves a patient gene expression signature that predicts severe sepsis, one of the significant diseases leading to antibiotic failure since antibiotics are the primary treatment for sepsis. Despite this, sepsis is responsible for nearly 20% of all deaths on the planet.See details»

Research Money Inc.

Sepset study to fast track diagnosis of sepsis Mark Henderson September 19, 2017. Sepset Biosciences Inc has started a multi-country and multi-center clinical study to develop faster and more accurate identification of patients afflicted with sepsis. The study is expected to assist in validating and refining the proprietary gene signature of Sepset, which is a spin-out of the …See details»

Sepset Biosciences Company Profile 2025: Valuation, Investors ...

Www.sepset.ca. Ownership Status. Acquired/Merged (Operating Subsidiary) Financing Status. Corporate Backed or Acquired. Corporate Office. 420 - 730 View Street; Victoria, British Columbia V8W 3S2; CanadaSee details»

World Sepsis Day - Sepset Biosciences Inc.

Sep 13, 2018 It was declared a Global Health Priority by the World Health Organization in 2017. As many as 80% of sepsis deaths in hospitals could be prevented with rapid diagnosis and treatment. Sepset Biosciences is developing a novel rapid diagnostic test that will enable healthcare professionals to provide earlier and more targeted treatment of sepsis.See details»

Sepset Biosciences - Products, Competitors, Financials, Employees ...

Sepset Biosciences Inc. ( sepset.ca ) is developing a diagnostic technology that involves a patient gene expression signature that helps assess the development of severe sepsis, one of the significant diseases leading to antibiotic failure, since antibiotics are the primary treatment for sepsis. Sepsis was responsible for nearly 20% of all ...See details»

Sepset Biosciences - Funding, Financials, Valuation & Investors

Jul 16, 2020 Sepset Biosciences has raised 2 rounds. Their latest funding was raised on Jul 16, 2020 from a Grant round. Sepset Biosciences is funded by 2 investors. Canadian Institutes of Health Research and Accel-Rx Health Sciences Accelerator are the most recent investors.See details»

Technology - Sepset Biosciences Inc.

Sepset is developing a blood-based test for hospitals to identify those patients in the emergency room (ER) and the intensive care unit (ICU) at a higher risk of developing sepsis and associated organ failure. Drs. Hancock, Pena and colleagues made a research breakthrough discovery that has substantial clinical implications . Their ...See details»

What is Sepset Biosciences? Company Culture, Mission, Values

Sepset Biosciences. Is this your company? This employer has not claimed their Employer Profile and is missing out on connecting with our community. Connect with our community. Claim your Free Employer Profile to start telling your employer brand story to reach top talent. Sepset Biosciences. Add a review.See details»

News_CAIVD & PCEM

Sepset Biosciences Inc. (sepset.ca) is developing a diagnostic technology that involves a patient gene expression signature that predicts severe sepsis, one of the significant diseases leading to antibiotic failure, since antibiotics are the primary treatment for sepsis. Despite this, sepsis is responsible for nearly 20% of all deaths on the ...See details»

Sepset Biosciences, Inc. (Sepset Biosciences, Inc.) - 药物管线_专利_ …

Sepset Biosciences Inc. (sepset.ca) is developing a diagnostic technology that involves a patient gene expression signature that helps assess the development of severe sepsis, one of the significant diseases leading to antibiotic failure, since antibiotics are the primary treatment for sepsis. Sepsis was responsible for nearly 20% of all deaths ...See details»

News — Sepset Biosciences Inc.

Jan 10, 2022 Despite decades of research, therapy for sepsis remains limited to supportive care, including early identification and intervention directed towards elimination of the physical focus of infection (commonly referred to as source control), and appropriate antibiotics. …See details»

What is a sepset in a probabilistic graphical model?

Mar 4, 2021 The terminology sepset is used quite often in the Probabilistic graphical models and causality. What does it mean and what is its relevance ? terminology; causality; graphical-model; definition; Share. Cite. Improve this question. Follow edited Mar 5, 2021 at 18:38. kjetil b ...See details»

What is Sepsis? - Sepset Biosciences Inc.

What is Sepsis? Sepsis is a serious condition where the immune system becomes unbalanced due to underlying infection(s) that lead to multiple organ failure and in 23% of cases, death, especially if not diagnosed early and treated promptly (Vincent, 2016).It is one of the most prevalent and deadly, yet misdiagnosed (Vincent, 2016), medical conditions.See details»

linkstock.net © 2022. All rights reserved